Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells

PARP1 and PARP2 play critical roles in regulating DNA repair and PARP inhibitors have been approved for the treatment of BRCA1/2-mutated ovarian and breast cancers. It has long been known that PARP inhibition sensitizes cancer cells to DNA-damaging cytotoxic agents independent of BRCA status, howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongge, Zhang, Shan, Song, Liyan, Qu, Meng, Zou, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118026/
https://www.ncbi.nlm.nih.gov/pubmed/32029902
http://dx.doi.org/10.1038/s41388-020-1191-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118026/
https://www.ncbi.nlm.nih.gov/pubmed/32029902
http://dx.doi.org/10.1038/s41388-020-1191-x

Ejemplares similares